BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17994190)

  • 1. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
    Retz W; Rösler M; Kissling C; Wiemann S; Hünnerkopf R; Coogan A; Thome J; Freitag C
    J Neural Transm (Vienna); 2008; 115(2):323-9. PubMed ID: 17994190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the presence of ADHD and certain candidate gene polymorphisms in a Turkish sample.
    Pazvantoğlu O; Güneş S; Karabekiroğlu K; Yeğin Z; Erenkuş Z; Akbaş S; Sarısoy G; Korkmaz IZ; Böke O; Bağcı H; Sahin AR
    Gene; 2013 Oct; 528(2):320-7. PubMed ID: 23872233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults.
    Halleland H; Lundervold AJ; Halmøy A; Haavik J; Johansson S
    Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):403-10. PubMed ID: 18802928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMT Val158Met variant and functional haplotypes associated with childhood ADHD history in women with bulimia nervosa.
    Yilmaz Z; Kaplan AS; Zai CC; Levitan RD; Kennedy JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):948-52. PubMed ID: 21300128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.
    Shang CY; Chiang HL; Gau SS
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():89-96. PubMed ID: 25554436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
    Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.
    Myer NM; Boland JR; Faraone SV
    Mol Psychiatry; 2018 Sep; 23(9):1929-1936. PubMed ID: 29230023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.
    Biederman J; Kim JW; Doyle AE; Mick E; Fagerness J; Smoller JW; Faraone SV
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1511-8. PubMed ID: 18937309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
    Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
    Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
    Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
    Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample.
    Cho SC; Kim JW; Kim BN; Hwang JW; Park M; Kim SA; Cho DY; Yoo HJ; Chung US; Son JW; Park TW
    Neuropsychobiology; 2008; 57(3):131-8. PubMed ID: 18552510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant.
    Pálmason H; Moser D; Sigmund J; Vogler C; Hänig S; Schneider A; Seitz C; Marcus A; Meyer J; Freitag CM
    J Neural Transm (Vienna); 2010 Feb; 117(2):259-67. PubMed ID: 19946713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechol-o-methyltransferase gene and executive function in children with ADHD.
    Choudhry Z; Sengupta S; Thakur G; Page V; Schmitz N; Grizenko N; Joober R
    J Atten Disord; 2014 Apr; 18(3):202-11. PubMed ID: 22451510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype.
    Eisenberg J; Mei-Tal G; Steinberg A; Tartakovsky E; Zohar A; Gritsenko I; Nemanov L; Ebstein RP
    Am J Med Genet; 1999 Oct; 88(5):497-502. PubMed ID: 10490706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.
    Lee SH; Kim SW; Lee MG; Yook KH; Greenhill LL; Fradin KN; Hong HJ
    Psychiatry Res; 2011 Apr; 186(2-3):338-44. PubMed ID: 20863575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in the catechol-O-methyltransferase Val 158 Met polymorphism associated with conduct disorder and ADHD symptoms, among adolescent male delinquents.
    DeYoung CG; Getchell M; Koposov RA; Yrigollen CM; Haeffel GJ; af Klinteberg B; Oreland L; Ruchkin VV; Pakstis AJ; Grigorenko EL
    Psychiatr Genet; 2010 Feb; 20(1):20-4. PubMed ID: 19997043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between catechol-O-methyltransferase (COMT) genotype and attention deficit hyperactivity disorder (ADHD) in Japanese children.
    Yatsuga C; Toyohisa D; Fujisawa TX; Nishitani S; Shinohara K; Matsuura N; Ikeda S; Muramatsu M; Hamada A; Tomoda A
    Brain Dev; 2014 Aug; 36(7):620-5. PubMed ID: 24035255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter gene and adverse life events in adult ADHD.
    Müller DJ; Mandelli L; Serretti A; DeYoung CG; De Luca V; Sicard T; Tharmalingam S; Gallinat J; Muglia P; De Ronchi D; Jain U; Kennedy JL
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1461-9. PubMed ID: 18214863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.
    Park S; Kim JW; Yang YH; Hong SB; Park MH; Kim BN; Shin MS; Yoo HJ; Cho SC
    Behav Brain Funct; 2012 May; 8():22. PubMed ID: 22591463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population.
    Joung Y; Kim CH; Moon J; Jang WS; Yang J; Shin D; Lee S; Kim KS
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):691-694. PubMed ID: 19685476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.